Matthew J Hepburn Selected Research

Matthew J Hepburn Research Topics

6	Infections 01/2021 - 08/2004
4	Tularemia 12/2009 - 09/2006
2	Anthrax 01/2016 - 04/2007
2	Smallpox (Variola) 04/2007 - 05/2004
2	Abscess 06/2006 - 08/2004
1	Hearing Loss (Hearing Impairment) 01/2021
1	Cutaneous anthrax 01/2016
1	Hemorrhage 09/2015
1	Wounds and Injuries (Trauma) 09/2015
1	Fever (Fevers) 08/2014
1	Arthritis (Polyarthritis) 02/2011
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 04/2007
1	Plague (Bubonic Plague) 04/2007
1	Septic Shock (Toxic Shock Syndrome) 04/2007
1	Sepsis (Septicemia) 04/2007
1	Soft Tissue Infections 06/2006
1	Bone Diseases (Bone Disease) 05/2005
1	Chronic Hepatitis C 12/2004
1	Inflammation (Inflammations) 12/2004
1	Liver Diseases (Liver Disease) 12/2004
1	Vaccinia 10/2004
1	Cellulitis 08/2004
1	Hepatitis C 08/2004
1	Pain (Aches) 09/2003

4	VaccinesIBA 01/2016 - 09/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2011 - 09/2003
2	AntibodiesIBA 01/2021 - 08/2014
2	AntigensIBA 01/2016 - 12/2009
1	Complement System Proteins (Complement)IBA 01/2021
1	CytokinesIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Anthrax Vaccines (Vaccines, Anthrax)IBA 01/2016
1	polyurethane foamIBA 09/2015
1	Immunoglobulin M (IgM)IBA 08/2014
1	Biological ProductsIBA 04/2007
1	Vancomycin FDA LinkGeneric 06/2006
1	beta-LactamsIBA 06/2006
1	Minocycline (Cyclops)FDA LinkGeneric 05/2005
1	oprelvekin (Neumega)FDA Link 12/2004
1	InterleukinsIBA 12/2004
1	Interleukin-11 (Interleukin 11)IBA 12/2004
1	Antiviral Agents (Antivirals)IBA 12/2004
1	Levofloxacin (Levaquin)FDA Link 08/2004

4	Therapeutics 06/2006 - 08/2004
2	Occlusive Dressings (Occlusive Dressing) 10/2004 - 05/2004